Richert J R, Robinson E D, Camphausen K, Martin R, Voskuhl R R, Faerber M A, McFarland H F, Hurley C K
Department of Neurology, Georgetown University Medical Center, Washington, DC 20007, USA.
Neurology. 1995 Oct;45(10):1919-22. doi: 10.1212/wnl.45.10.1919.
We sequenced the cDNAs of alpha and beta T-cell receptors (TCRs), including V, J, and CDR3 regions, expressed by 54 myelin basic protein (MBP)-specific T-cell clones generated from the peripheral blood of 15 multiple sclerosis (MS) patients and three normal controls. Thirteen V alpha gene segments, 18 V beta gene segments, 23 CDR3 alpha sequences, and 30 CDR3 beta sequences were represented among these clones. Some CDR3 motifs were common to several clones that shared epitope specificity, while other motifs were common to clones with diverse epitope specificities. The extensive heterogeneity of TCR gene expression in the human immune response to MBP indicates that therapeutic strategies aimed at blocking a limited number of TCRs are unlikely to fully suppress the T-cell response to MBP in vivo.
我们对15例多发性硬化症(MS)患者和3名正常对照外周血中产生的54个髓鞘碱性蛋白(MBP)特异性T细胞克隆所表达的α和β T细胞受体(TCR)的cDNA进行了测序,包括V、J和CDR3区域。这些克隆中代表了13个Vα基因片段、18个Vβ基因片段、23个CDR3α序列和30个CDR3β序列。一些CDR3基序在具有共同表位特异性的几个克隆中是常见的,而其他基序在具有不同表位特异性的克隆中是常见的。人类对MBP免疫反应中TCR基因表达的广泛异质性表明,旨在阻断有限数量TCR的治疗策略不太可能在体内完全抑制T细胞对MBP的反应。